These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23271435)

  • 21. Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery.
    Alameh M; Dejesus D; Jean M; Darras V; Thibault M; Lavertu M; Buschmann MD; Merzouki A
    Int J Nanomedicine; 2012; 7():1399-414. PubMed ID: 22457597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards breast cancer therapy.
    Wu X; Zheng Y; Yang D; Chen T; Feng B; Weng J; Wang J; Zhang K; Zhang X
    J Mater Chem B; 2019 Jan; 7(3):477-487. PubMed ID: 32254735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of antiapoptotic genes in breast cancer cells by siRNA loaded into hybrid nanoparticles.
    de Mello LJ; Souza GR; Winter E; Silva AH; Pittella F; Creczynski-Pasa TB
    Nanotechnology; 2017 Apr; 28(17):175101. PubMed ID: 28230534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-delivery of chemosensitizing siRNA and an anticancer agent via multiple monocomplexation-induced hydrophobic association.
    Lee E; Oh C; Kim IS; Kwon IC; Kim S
    J Control Release; 2015 Jul; 210():105-14. PubMed ID: 25979325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
    Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
    Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells.
    Malhotra M; Kulamarva A; Sebak S; Paul A; Bhathena J; Mirzaei M; Prakash S
    Drug Dev Ind Pharm; 2009 Jun; 35(6):719-26. PubMed ID: 19514987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
    Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
    Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
    Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
    Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of apoptosis by chitosan/HPV16 E7 siRNA complexes in cervical cancer cells.
    Yang J; Li S; Guo F; Zhang W; Wang Y; Pan Y
    Mol Med Rep; 2013 Mar; 7(3):998-1002. PubMed ID: 23258711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of Transforming Growth Factor-β1 siRNA Loaded Chitosan-Tripolyphosphate Nanoparticles for the Treatment of Colorectal Cancer Hepatic Metastasis in a Mouse Model.
    Fang JK; Chen L; Lu XG; Cao D; Guo LL; Zhang YS; Li LB; Zhang LF; Kuang YT; Wang SL
    J Biomed Nanotechnol; 2016 Jul; 12(7):1489-1500. PubMed ID: 29337488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of chitosan/siRNA and trimethylchitosan/siRNA complexes behaviour in vitro.
    Dehousse V; Garbacki N; Jaspart S; Castagne D; Piel G; Colige A; Evrard B
    Int J Biol Macromol; 2010 Apr; 46(3):342-9. PubMed ID: 20096725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery.
    Lee DW; Yun KS; Ban HS; Choe W; Lee SK; Lee KY
    J Control Release; 2009 Oct; 139(2):146-52. PubMed ID: 19567259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: sequential delivery of doxorubicin and Bcl-2 siRNA.
    Yoon HY; Son S; Lee SJ; You DG; Yhee JY; Park JH; Swierczewska M; Lee S; Kwon IC; Kim SH; Kim K; Pomper MG
    Sci Rep; 2014 Nov; 4():6878. PubMed ID: 25363213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymer Based Gene Silencing: In Vitro Delivery of SiRNA.
    Carlos MI; Schätzlein A; Uchegbu I
    Methods Mol Biol; 2016; 1445():149-57. PubMed ID: 27436317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma.
    Shen M; Gong F; Pang P; Zhu K; Meng X; Wu C; Wang J; Shan H; Shuai X
    Int J Nanomedicine; 2012; 7():3319-32. PubMed ID: 22802690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
    Gu J; Al-Bayati K; Ho EA
    Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
    Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
    Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of tripolyphosphate on cellular uptake and RNA interference efficiency of chitosan-based nanoparticles in Raw 264.7 macrophages.
    Xiao B; Ma P; Ma L; Chen Q; Si X; Walter L; Merlin D
    J Colloid Interface Sci; 2017 Mar; 490():520-528. PubMed ID: 27918990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.